🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Status
Terminated
Location
Usc La Nichd Crs
Start Date
2021-09-01
Trial ID
NCT04518228
Treatments Being Tested
This study is based on the hypothesis that the pharmacokinetics of anti-tub...
Status
Recruiting
Location
Beijing Children's Hospital of Capital Medical University
Start Date
2018-07-01
Trial ID
NCT03625739
Treatments Being Tested
This trial is to describe the safety, tolerability and exposure-toxicity re...
Status
Completed
Location
The Aurum Institute Tembisa Clinical Research Centre
Start Date
2021-10-28
Trial ID
NCT04550832
Treatments Being Tested
This is a phase 2B, open label study, that will compare the safety and effi...
Status
Unknown
Location
TASK Applied Sciences Clinical Research Centre
Start Date
2023-09-21
Trial ID
NCT05926466
Treatments Being Tested
The UNITE4TB consortium is a group of universities and pharmaceutical compa...
Status
Recruiting
Location
PMSI Institute of Pneumology "Chiril Draganiuc"
Start Date
2024-01-09
Trial ID
NCT06114628
The goal of this clinical trial is to compare the efficacy and safety of a ...
Status
Active Not Recruiting
Location
Beijing Chest Hospital affiliated to Capital Medical University
Start Date
2023-12-22
Trial ID
NCT06081361
The purpose of this study is to determine whether one or two 17-week regime...
Status
Active Not Recruiting
Location
TBTC Site 26 Seattle & King County TB Control Program
Start Date
2023-11-21
Trial ID
NCT05766267
Treatments Being Tested
This study measured the early bactericidal activity (EBA), safety, tolerabi...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-07-26
Trial ID
NCT05382312
Treatments Being Tested
Rifampicin-resistant tuberculosis (RR-TB) is characterized by a long treatm...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07126639
Treatments Being Tested
This study is an open-label, randomized, controlled, multi-center Phase IIB...
Status
Completed
Location
The Aurum Institute for Health Research
Start Date
2021-05-06
Trial ID
NCT03959566
Treatments Being Tested